Vas Narasimhan named to 2025 TIME100 Health list
Vas Narasimhan named to 2025 TIME100 Health list
angilma1
Tue, 05/06/2025 – 15:31
Read more about Vas Narasimhan named to 2025 TIME100 Health list
PrintPDF
Entries by angilma1
Europe talks health sovereignty — now it must deliver
Europe talks health sovereignty — now it must deliver
angilma1
Wed, 04/23/2025 – 18:59
Read more about Europe talks health sovereignty — now it must deliver
PrintPDF
Europe talks health sovereignty — now it must deliver
Europe talks health sovereignty — now it must deliver
angilma1
Wed, 04/23/2025 – 18:59
Read more about Europe talks health sovereignty — now it must deliver
PrintPDF
Europe talks health sovereignty — now it must deliver
Europe talks health sovereignty — now it must deliver
angilma1
Wed, 04/23/2025 – 18:59
Read more about Europe talks health sovereignty — now it must deliver
PrintPDF
Addressing unmet needs for inherited neuromuscular diseases
Addressing unmet needs for inherited neuromuscular diseases
angilma1
Thu, 11/21/2024 – 12:45
Read more about Addressing unmet needs for inherited neuromuscular diseases
PrintPDF
Negative impact of the IRA on patient access to innovative treatments
Negative impact of the IRA on patient access to innovative treatments
angilma1
Thu, 08/15/2024 – 14:46
Read more about Negative impact of the IRA on patient access to innovative treatments
PrintPDF
Negative impact of the IRA on patient access to innovative treatments
Negative impact of the IRA on patient access to innovative treatments
angilma1
Thu, 08/15/2024 – 14:46
Read more about Negative impact of the IRA on patient access to innovative treatments
PrintPDF
Novartis statement on Maximum Fair Price for Entresto
Novartis statement on Maximum Fair Price for Entresto
angilma1
Thu, 08/15/2024 – 14:36
Read more about Novartis statement on Maximum Fair Price for Entresto
PrintPDF
Novartis statement on Maximum Fair Price for Entresto
Novartis statement on Maximum Fair Price for Entresto
angilma1
Thu, 08/15/2024 – 14:36
Read more about Novartis statement on Maximum Fair Price for Entresto
PrintPDF
Novartis Financial Results – Q2 2024
Novartis Financial Results – Q2 2024
angilma1
Mon, 07/15/2024 – 11:49
Read more about Novartis Financial Results – Q2 2024
PrintPDF
